Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Zanamivir

Known as: ATC code J05AH01, ATCvet code QJ05AH01, Relenza 
Zanamivir INN /zəˈnæmᵻvɪər/ is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It… Expand
Wikipedia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Bacterial infections are still one of the main causes of disease around the world. For this reason, the early diagnosis of an… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2016
Review
2016
All patients received the following treatments: • Antiviral therapy in recommended doses (neuraminidase inhibitors Relenza… Expand
  • table 1
  • table 2
Is this relevant?
2009
2009
  • 2009
  • Corpus ID: 195168254
 
Is this relevant?
Review
2007
Review
2007
Deutschland sowie Faktoren, die zu diesem Verhalten führen, identifiziert werden. In den vom RKI durchgeführten telefonischen… Expand
Is this relevant?
2006
2006
Although influenza pandemics have plagued mankind for centuries, a pandemic resulting from the current H5N1 threat would be a… Expand
Is this relevant?
2001
2001
  • International Journal of Pharmaceutical Medicine
  • 2001
  • Corpus ID: 20862910
 
Is this relevant?
2000
2000
[Glaxo Wellcome responds:] Deena Ages notes that the patient information pamphlet for Relenza does not include the statement in… Expand
Is this relevant?